Illumina's early access duplex sequencing workflow for MRD and tumor evolution research pairs NovaSeq X with DRAGEN to support the detection of trace ctDNA in plasma.

Discovery offers new insights into the processes that drive cell proliferation and may influence cancer growth, and could ...

Computer-designed protein therapeutics move from proof-of-concept to wet-lab validation and even clinical trials as the field ...

Nurix Therapeutics suffered its worst one-day loss as a public company Wednesday, nosediving 38% after Sanofi terminated ...

Novartis has confirmed nine instances—seven of them newly disclosed—in which tumors have developed in children treated with its marketed spinal muscular atrophy gene therapy Zolgensma® (onasemnogene ...

Researchers say to their knowledge the study represents the largest study to date of PFAS exposure and breast cancer incidence, particularly for ER-tumors.

Not all DNA damage is equal. Every time a cell divides, it has to copy its DNA, and some stretches of the genome are harder to copy than others. Cancer cells depend on a protective response to get ...

Researchers at the University of Cambridge and Cambridge’s spin-out DIOSynVax, along with collaborators, reported on the ...

Its first program is an investigational therapy program for ornithine transcarbamylase deficiency, a rare, X-linked metabolic disorder.

Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerative medicine toward broader clinical use.

Despite this advance, conventional CRISPR-Cas9 systems may introduce potentially harmful DNA breaks and cannot easily be ...

Principal Scientist, USP While payload design will remain a primary focus, the next era of innovation in CGT may ultimately ...